Abbott Laboratories (NYSE:ABT) | Abbott Expands Latin American Presence and Branded Generics Portfolio with Acquisition of CFR Pharmaceuticals

[PR Newswire] – ABBOTT PARK, Ill., May 16, 2014 /PRNewswire/ — Abbott (ABT) today announced a definitive agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals, more than doubling its Latin American branded . . . → Read More: Abbott Laboratories (NYSE:ABT) | Abbott Expands Latin American Presence and Branded Generics Portfolio with Acquisition of CFR Pharmaceuticals Similar Articles: Company Update (NYSE:GE): Leading forensic laboratories participate in independent validation of the GE Healthcare Life Sciences and NetBio Rapid DNA system Abbott Laboratories (NYSE:ABT) – Abbott to Present at Deutsche Bank 39th Annual Health Care Conference Company Update (NYSE:GE): GE completes acquisition of strategic assets from Thermo Fisher Scientific